(Q39274136)

10 September 2017

title

Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response (English)

1 reference

10 September 2017

0 references

1 reference

Cheng Chen

1

1 reference

10 September 2017

Yu Shen

2

1 reference

10 September 2017

Qiu-Xia Qu

3

1 reference

10 September 2017

Xu-Qin Chen

4

1 reference

10 September 2017

Xue-Guang Zhang

5

1 reference

10 September 2017

Jian-An Huang

6

1 reference

10 September 2017

language of work or name

English

0 references

publication date

19 September 2012

1 reference

Experimental Cell Research

10 September 2017

published in

1 reference

10 September 2017

volume

319

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

96-102

1 reference

Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

B7-H1 pathway and its role in the evasion of tumor immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

Role of tumor-associated macrophages in tumor progression and invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

Mouse B7-H3 induces antitumor immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

Murine B7-H3 is a negative regulator of T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

Cyclic adenosine monophosphate and IL-10 coordinately contribute to nTreg cell-mediated suppression of dendritic cell activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

Clinical importance of B7-H3 expression in human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

B7-H3 and B7-H4 expression in non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.006

10.1016/J.YEXCR.2012.09.006

7 January 2021

Identifiers

DOI

1 reference

10 September 2017

1 reference